Biopsy technique and biopsy schemes for a first series of prostatic biopsies;Conditions de réalisation et schéma de ponctions lors d'une première série de biopsies prostatiques

Progres en Urologie

Volumn 14, Issue 2, 2004, Pages 144-153

  Villers, Arnauld ^a   Mouton, Damien ^a   Rébillard, Xavier ^b   Chautard, Denis ^c   Ruffion, Alain ^d   Staerman, Frédéric ^e   Cornud, François ^f  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Clinique Beausoleil   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e REIMS UNIVERSITY HOSPITAL   (France)

^f Service de Radiologie   (France)

Author keywords

Biopsy; Diagnosis; Imaging; Prostate neoplasms; Screening

Indexed keywords

ANTIBIOTIC AGENT;

BIOPSY TECHNIQUE; CLINICAL EXAMINATION; CLINICAL TRIAL; HUMAN; INFECTION; LOCAL ANESTHESIA; MORBIDITY; PROPHYLAXIS; PROSTATE BIOPSY; PROSTATE CARCINOMA; REVIEW; RISK ASSESSMENT;

BIOPSY, NEEDLE; CLINICAL PROTOCOLS; HUMANS; MALE; PROSTATE;

EID: 3042600839     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. ALAVI A.S., SOLOWAY M.S., VAIDYA A., LYNNE C.M., AND GHEILER E.L. : Local anesthesia for ultrasound guided prostate biopsy : a prospective randomized trial comparing 2 methods. J. Urol., 166 : 1343-1345 ; 2001.
2. ARON M., RAJEEV T.P., AND GUPTA N.P. : Antibiotic prophylaxis for transrectal needle biopsy of the prostate : a randomized controlled study. BJU Int., 85 : 682-685 ; 2000.
3. AUBERT J. : Complications of prostatic biopsies. Analysis of a series of 4,764 biopsies. Prog. Urol., 2 : 484-487 ; 1992.
4. AUSTENFELD M.S. : Preoperative estimate of extent of disease in T1c : how well can we predict ? Semin. Urol. Oncol., 13 : 176-180 ; 1995.
5. BABAIAN R.J., TOI A., KAMOI K., TRONCOSO P., SWEET J., EVANS R., JOHNSTON D., AND CHEN M. : A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J. Urol., 163 : 152-715 ; 2000.
6. BAUER J.J., ZENG J., WEIR J., ZHANG W., SESTERHENN I.A., CONNELLY R.R., MUN S.K., AND MOUL J.W. : Three-dimensional computer-simulated prostate models : lateral prostate biopsies increase the detection rate of prostate cancer. Urology, 53 : 961-967 ; 1999.
7. BAZINET M., KARAKIEWICZ RL, APRIKIAN A.G., TRUDEL C., ARONSON S., NACHABE M., PELOQUIN F., DESSUREAULT J., GOYAL M., ZHENG W., BEGIN L.R., AND ELHILALI M.M. : Value of systematic transition zone biopsies in the early detection of prostate cancer. J. Urol., 155 : 605-606 ; 1996.
8. BEURTON D.B.Y., FONTAINE E. : Twelve systematic prostate biopsies are superior to sextant biopsies for diagnosting carcinoma : a prospective randomized study. Br. J. Urol., 80 : 239 ; 1997.
9. BRAWER M.K., BENSON M.C., BOSTWICK D.G., DJAVAN B., LILJA H., SEMJONOW A., SU S., AND ZHOU Z. : Prostate-specific antigen and other serum markers: current concepts from the World Health Organization Second International Consultation on Prostate Cancer. Semin. Urol. Oncol., 17 : 206-221 ; 1999.
10. BRAWER M.K., CHETNER M.P., BEATIE J., BUCHNER D.M., VESSELLA R.L., AND LANGE P.H. : Screening for prostatic carcinoma with prostate specific antigen. J. Urol., 147 : 841-845 ; 1992.
11. CAREY J.M., AND KORMAN H.J. : Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J. Urol., 166 : 82-85 ; 2001.
12. CATALONA W.J., RICHIE J.P., AHMANN F.R., HUDSON M.A., SCARDINO P.T., FLANIGAN R.C., DEKERNION J.B., RATLIFF T.L., KAVOUSSI L.R., DALKIN B.L., AND ET AL. : Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer : results of a multicenter clinical trial of 6,630 men. J. Urol., 151 : 1283-1290 ; 1994.
13. CATALONA W.J., SMITH D.S., RATLIFF T.L., DODDS K.M., COPLEN D.E., YUAN J.J., PETROS J.A., AND ANDRIOLE G.L. : Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med., 324 : 1156-1161 ; 1991.
14. CHANG J.J., SHINOHARA K., BHARGAVA V., AND PRESTI J.C., JR. : Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J. Urol., 160 : 2111-2114 ; 1998.
15. DE LA TAILLE A., ANTIPHON P., SALOMON L., CHERFAN M., ET AL.: Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology, 2003 ; 61 : 1181-1186.
16. DESGRANDCHAMPS F., MERIA P., IRANI J., DESGRIPPES A., TEILLAC P., AND LE DUC A. : The rectal administration of lidocaine gel and tolerance of transrectal ultrasonography-guided biopsy of the prostate: a prospective randomized placebo-controlled study. BJU Int., 83 : 1007-1009 ; 1999.
17. DIETRICK D.D., MCNEAL J.E., AND STAMEY T.A. : Core cancer length in ultrasound-guided systematic sextant biopsies : a preoperative evaluation of prostate cancer volume. Urology, 45 : 987-992 ; 1995.
18. DJAVAN B., KADESKY K., KLOPUKH B., MARBERGER M., AND ROEHRBORN C.G. : Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict Gleason scores of radical prostatectomy specimens. Eur. Urol., 33 : 261-270 ; 1998.
19. ELLIS W.J., CHETNER M.P., PRESTON S.D., AND BRAWER M.K. : Diagnosis of prostatic carcinoma : the yield of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography. J. Urol., 152 : 1520-1525 ; 1994.
20. EPSTEIN J.I., AND POTTER S.R. : The pathological interpretation and significance of prostate needle biopsy findings : implications and current controversies. J. Urol. 166 : 402-410 ; 2001.
21. EPSTEIN J.I., WALSH P.C., AND BRENDLER C.B. : Radical prostatectomy for impalpable prostate cancer : the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). J. Urol., 152 : 1721-1729 ; 1994.
22. EPSTEIN J.I., WALSH P.C., AND CARTER H.B. : Importance of posterolateral needle biopsies in the detection of prostate cancer. Urology, 57 : 1112-1116 ; 2001.
23. ESKEW L.A., BARE R.L., AND MCCULLOUGH D.L. : Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J. Urol., 157 : 199-202 ; 1997.
24. ESKEW L.A., WOODRUFF R.D., BARE R.L., AND MCCULLOUGH D.L. : Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J. Urol., 160 : 794-796 ; 1998.
25. FINK K.G., HUTAREW G., ESTERBAUER B., PYTEL A., JUNGWIRTH A., DIETZE O., AND SCHMELLER N.T. : Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy. Urology, 61 : 748-753 ; 2003.
26. FLESHNER N.B., AND FAIR W.R. : Indications for transition zone biopsy in the detection of prostatic carcinoma. J. Urol., 157 : 556-558 ; 1997.
27. FOWLER J.E. JR., BIGLER S.A., KILAMBI N.K., AND LAND S.A. : Results of transition zone biopsy in black and white men with suspected prostate cancer. Urology, 53 : 346-350 ; 1999.
28. GORE J.L., SHARIAT S.F., MILES B.J., KADMON D., JIANG N., WHEELER T.M., AND SLAWIN K.M. : Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J. Urol., 165 : 1554-1559 ; 2001.
29. GRIFFITH B.C., MOREY A.F., ALI-KHAN M.M., CANBY-HAGINO E., FOLEY J.P., AND ROZANSKI T.A. : Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J. Urol., 168 : 1021-1023 ; 2002.
30. GROSCLAUDE P., MENEGOZ F., SCHAFFER P., MACE LESEC'H J., ARVEUX P., LE MAB G., SOULIE M., AND VILLERS A. : Prostate cancer screening (II) : is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990. Prog. Urol., 7 : 647-654 ; 1997.
31. GROSSKLAUS D.J., COFFEY C.S., SHAPPELL S.B., JACK G.S., CHANG S.S., AND COOKSON M.S. : Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J. Urol., 167 : 2032-2035; 2002.
32. HERGET E.J., SALIKEN J.C., DONNELLY B.J., GRAY R.R., WISEMAN D., AND BRUNET G. : Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. Can. Assoc. Radiol. J., 50 : 173-176 ; 1999.
33. HODGE K.K., MCNEAL J.E., AND STAMEY T.A. : Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J. Urol., 142 : 66-70 ; 1989.
34. HODGE K.K., MCNEAL J.E., TERRIS M.K., AND STAMEY T.A. : Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol., 142 : 71-74 ; 1989.
35. IRANI J., FOURNIER F., BON D., GREMMO E., DORE B., AND AUBERT J. : Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. Br. J. Urol., 79 : 608-610 ; 1997.
36. ISSA M.M., BUX S., CHUN T., PETROS J.A., LABADIA A.J., ANASTASIA K., MILLER L.E., AND MARSHALL F.F. : A randomized prospective trial of intrarectal lidocaine for pain control during transrectal prostate biopsy : the Emory University experience. J. Urol. 164 : 397-399 ; 2000.
37. JONES J.S., ODER M., AND ZIPPE C.D. : Saturation prostate biopsy with periprostatic block can be performed in office. J. Urol., 168 : 2108-2110 ; 2002.
38. LEIBOVICI D., ZISMAN A., SIEGEL Y.I., SELLA A., KLEINMANN J., AND LINDNER A. : Local anesthesia for prostate biopsy by periprostatic lidocaine injection : a double-blind placebo controlled study. J. Urol., 167 : 563-565 ; 2002.
39. LINDERT K.A., KABALIN J.N., AND TERRIS M.K. : Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J. Urol., 164 : 76-80 ; 2000.
40. LIU I.J., MACY M., LAI Y.H., AND TERRIS M.K. : Critical evaluation of the current indications for transition zone biopsies. Urology, 57 : 1117-1120 ; 2001.
41. LUI P.D., TERRIS M.K., MCNEAL J.E., AND STAMEY T.A. : Indications for ultrasound guided transition zone biopsies in the detection of prostate cancer. J. Urol., 153 : 1000-1003 ; 1995.
42. MCGREGOR R., KEIR J.A., WILSON G. & DAWSON C. : A novel way of controlling rectal bleeding after transrectal ultrasonography-guided prostate biopsies. BJU International, 91 : 428 ; 2003.
43. MOROTE J., LOPEZ M., ENCABO G., AND DE TORRES I. : Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time. Eur. Urol., 35 : 294-297 ; 1999.
44. NASH P.A., BRUCE J.E., INDUDHARA R., AND SHINOHARA K. : Transrectal ultrasound guided prostatic nerve blockade eases systematic needle biopsy of the prostate. J. Urol., 155 : 607-609 ; 1996.
45. NAUGHTON C.K., ORNSTEIN D.K., SMITH D.S., AND CATALONA W.J. : Pain and morbidity of transrectal ultrasound guided prostate biopsy : a prospective randomized trial of 6 versus 12 cores. J. Urol., 163 : 168-171 ; 2000.
46. NORBERG M., EGEVAD L., HOLMBERG L., SPAREN P., NORLEN B.J., AND BUSCH C. : The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology, 50 : 562-566 ; 1997.
47. ONDER A.U., YALCIN V., ARAR O., YAYCIOGLU O., CITCI A., AND SOLOK V : Impact of transition zone biopsies in detection and evaluation of prostate cancer. Eur. Urol., 33 : 542-548 ; 1998.
48. PAREEK G., ARMENAKAS N.A., AND FRACCHIA J.A. : Periprostatic nerve blockade for transrectal ultrasound guided biopsy of the prostate : a randomized, double-blind, placebo controlled study. J. Urol., 166 : 894-897 ; 2001.
49. PELLER P.A., YOUNG D.C., MARMADUKE D.P., MARSH W.L., AND BADALAMENT R.A. : Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer, 75 : 530-8 ; 1995.
50. PEYROMAURE M., RAVERY V., AND BOCCON-GIBOD L. : Biopsies de la zone de transition : impact sur la détection du cancer prostatique et valeur pronostique. Prog. Urol., 12 : 8-14 ; 2002.
51. POTTER S.R., HORNIGER W., TINZL M., BARTSCH G., AND PARTIN A.W. : Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology, 57 : 1100-1104 ; 2001.
52. PRESTI J.C. JR., CHANG J.J., BHARGAVA V., AND SHINOHARA K. : The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies : results of a prospective clinical trial. J. Urol., 163 : 163-166 ; 2000.
53. PRESTI J.C. JR., O'DOWD G.J., MILLER M.C., MATTU R., AND VELTRI R. W. : Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates : results of a community multi-practice study. J. Urol., 169 : 125-9 ; 2003.
54. Raaijmakers R., Kirkels W.J., Roobol M.J., Wildhagen M.F., and Schrder F.H. : Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology, 60 : 826-830 ; 2002.
55. RAVERY V., BOCCON-GIBOD L.A., DAUGE-GEFFROY M.C., BILLEBAUD T., DELMAS V., MEULEMANS A., TOUBLANC M., AND BOCCON-GIBOD L. : Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology, 44 : 371-376 ; 1994.
56. RAVERY V., BOCCON-GIBOD L.A., MEULEMANS A., DAUGE-GEFFROY M.C., TOUBLANC M., AND BOCCON-GIBOD L. : Predictive value of pathological features for progression after radical prostatectomy. Eur. Urol., 26 : 197-201 ; 1994.
57. RAVERY V., DE LA TAILLE A., TOUBLANC M., BOCCON-GIBOD L., HERMIEU J.F., AND DELMAS V : Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence. J. Urol. 155 : 1981-1982 ; 1996.
58. RAVERY V., FONTAINE E., AND VILLERS A. : Prostatic biopsies : technical modalities and conditions of the test. Prog. Urol., 10 : 1271-1276 ; 2000.
59. RAVERY V., GOLDBLATT L., ROYER B., BLANC E., TOUBLANC M., AND BOCCON-GIBOD L. : Extensive biopsy protocol improves the detection rate of prostate cancer. J. Urol., 164 : 393-396 ; 2000.
60. RAVERY V., SCHMID H.P., TOUBLANC M., AND BOCCON-GIBOD L.: Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma? Cancer, 78 : 1079-1084 ; 1996.
61. RODRIGUEZ L.V., AND TERRIS M.K. : Risks and complications of transrectal ultrasound guided prostate needle biopsy : a prospective study and review of the literature. J. Urol., 160 : 2115-2120 ; 1998.
62. SAAD F., SABBAGH R., MCCORMACK M., AND FP F.P. : A prospective randomized trial comparing lidocaine and lubrificating gel on pain level in patients undergoing transrectal ultrasound prostate biopsy. Can. J. Urol., 9 : 1592-1594 ; 2002.
63. SCHERR D.S., EASTHAM J., OHORI M., AND SCARDINO P.T. : Prostate biopsy techniques and indications : when, where, and how? Semin. Urol. Oncol., 20 : 18-31 ; 2002.
64. SMITH D.S., CATALONA, W.J., AND HERSCHMAN J.D. : Longitudinal screening for prostate cancer with prostate-specific antigen. Jama, 276 : 1309-1315 ; 1996.
65. SOLOWAY M.S., AND OBEK C. : Periprostatic local anesthesia before ultrasound guided prostate biopsy. J. Urol., 163 : 172-173 ; 2000.
66. STEWART C.S., LEIBOVICH B.C., WEAVER A.L., AND LIEBER M.M.: Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J. Urol., 166 : 86-91 ; 2001.
67. TERRIS M.K., PHAM T.Q., ISSA M.M., AND KABALIN J.N. : Routine transition zone and seminal vesicle biopsies in all patients undergoing transrectal ultrasound guided prostate biopsies are not indicated. J. Urol., 157 : 204-206 ; 1997.
68. VALLANCIEN G., BOCHEREAU G., WETZEL O., BRETHEAU D., DEBRAS B., BOUGARAN Y., AND GUILLONNEAU B. : Biopsy of the seminal vesicles in the staging of localized cancer of the prostate : technic and results. Prog. Urol., 7 : 42-47 ; 1997.
69. WEBB N.R., AND WOO H.H. : Antibiotic prophylaxis for prostate biopsy. BJU Int., 89 : 824-828 ; 2002.
70. WESTENBERG A.M., COSSAR E.H., LORIMER L.B., AND COSTELLO J.P. : The acceptability of transrectal ultrasound guided prostatic biopsy without anaesthesia. N Z Med. J., 112 : 231-232 ; 1999.
71. WU C.L., CARTER H.B., NAQIBUDDIN M., AND FLEISHER L.A. : Effect of local anesthetics on patient recovery after transrectal biopsy. Urology, 57 : 925-929 ; 2001.
72. ZENG J., BAUER J., ZHANG W., SESTERHENN I., CONNELLY R., LYNCH J., MOUL J., AND MUN S.K. : Prostate biopsy protocols : 3D visualization-based evaluation and clinical correlation. Comput Aided Surg., 6 : 14-21 ; 2001.